Malignant Pleural Mesothelioma
📧 Sign up to get email alerts when something new happens for Malignant Pleural Mesothelioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-04-25Clinical Trial Update: dENdritic Cell Therapy Combined With SURgEry in Mesothelioma [Phase 1]
Phase 1 trial of dendritic cell therapy combined with surgery for malignant pleural mesothelioma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-08Clinical Trial Update: Hemithoracic Arc Radiotherapy Post Pleural Decortication [NA]
A clinical trial evaluating hemithoracic arc radiotherapy after pleural decortication for malignant pleural mesothelioma is currently recrui…
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO
This clinical trial update announces ongoing recruitment for the TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO study led by Un…
-
CLINICAL_TRIALS research · 2025-03-20Clinical Trial Update: Genetic Susceptibility in MAlignant Pleural Mesothelioma: Clinical Implication of GermliNE variaTionS
This document provides an update on a clinical trial investigating genetic susceptibility in malignant pleural mesothelioma and the clinical…
-
CLINICAL_TRIALS research · 2025-03-13Clinical Trial Update: Atezolizumab Versus Placebo for the Adjuvant Treatment of Malignant Pleural Mesothelioma (Atezomeso) [Phase 3]
This is a Phase 3 clinical trial evaluating atezolizumab versus placebo as adjuvant therapy for malignant pleural mesothelioma, currently re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-11-05Clinical Trial Update: Pembrolizumab Plus Lenvatinib In Second Line and Third Line Malignant Pleural mesotheLioma Patients [Phase 2]
This is a Phase 2 clinical trial assessing pembrolizumab plus lenvatinib in second- and third-line malignant pleural mesothelioma, with the …
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Identification of Prognostic and Predictive Biomarkers of Toxicity in Patients With Malignant Pleural Mesothelioma and Treated With High Doses of Radiotherapy (MESORTIBO)
A clinical trial (MESORTIBO) investigating prognostic and predictive biomarkers of toxicity in patients with malignant pleural mesothelioma …
-
CLINICAL_TRIALS research · 2024-06-11Clinical Trial Update: Ga-68 FAPI PET Before Immunotherapy [NA]
This is an administrative update on a clinical trial sponsored by Ankara University assessing Ga-68 FAPI PET imaging before immunotherapy fo…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating the combination of atezolizumab and WT1 dendritic cell vaccination with platinum/pemetrexed-based f…
-
CLINICAL_TRIALS research · 2018-07-23Clinical Trial Update: The ISET (Isolation by Size of Epithelial Tumor Cells) and the CellSearch Methods in Malignant Pleural Mesothelioma [NA]
This update summarizes a completed clinical trial comparing the ISET (Isolation by Size of Epithelial Tumor Cells) and CellSearch methods in…
-
CLINICAL_TRIALS research · 2018-02-23Clinical Trial Update: Effect of Expression of CD74 and VEGF on Outcome of Treatment in Patients With Malignant Pleural Mesothelioma
A clinical trial investigating how the expression of CD74 and VEGF affects treatment outcomes in patients with malignant pleural mesotheliom…
-
CLINICAL_TRIALS research · 2017-04-07Clinical Trial Update: MesomiR 1: A Phase I Study of TargomiRs as 2nd or 3rd Line Treatment for Patients With Recurrent MPM and NSCLC [Phase 1]
Phase I study of MesomiR-1 (TargomiRs) for recurrent malignant pleural mesothelioma and non-small cell lung cancer; the trial status is comp…
-
CLINICAL_TRIALS research · 2016-11-21Clinical Trial Update: uPAR-PET for Prognostication in Patients With Non-small Cell Lung Cancer, Malignant Pleural Mesothelioma and Large Cell Neuroendocrine Carcinoma of the Lung [Phase 2]
Clinical trial update describing Phase 2 evaluation of uPAR-PET imaging as a prognostic tool in patients with Non-small cell lung cancer, ma…
-
CLINICAL_TRIALS research · 2015-08-06Clinical Trial Update: Response Evaluation in Malignant Pleural Mesothelioma
This update provides information on the clinical trial NCT00969098 evaluating response evaluation in malignant pleural mesothelioma.
-
CLINICAL_TRIALS research · 2015-07-14Clinical Trial Update: Four Versus Six Cycles of Pemetrexed/Platinum for MPM [Phase 2]
An update on a Phase 2 trial comparing four versus six cycles of pemetrexed/platinum therapy for malignant pleural mesothelioma.
-
CLINICAL_TRIALS research · 2015-01-30Clinical Trial Update: Thromboelastography During Surgery for Malignant Pleural Mesothelioma
This entry reports on an ongoing clinical trial evaluating thromboelastography during surgery for malignant pleural mesothelioma, sponsored …
-
CLINICAL_TRIALS research · 2013-03-12Clinical Trial Update: A Phase II Trial to Assess TroVax® Plus Chemotherapy in Patients With Malignant Pleural Mesothelioma [Phase 2]
Phase II trial update evaluating TroVax in combination with chemotherapy for malignant pleural mesothelioma.
-
CLINICAL_TRIALS research · 2011-10-31Clinical Trial Update: Velcade and Eloxatin for Patients With Malignant Pleural or Peritoneal Mesothelioma [Phase 2]
Phase 2 trial evaluating Velcade (bortezomib) and Eloxatin (oxaliplatin) for malignant pleural or peritoneal mesothelioma. The current statu…
-
CLINICAL_TRIALS research · 2011-04-28Clinical Trial Update: Trimodality Therapy for Malignant Pleural Mesothelioma
A clinical trial update on trimodality therapy for malignant pleural mesothelioma (NCT01343264) sponsored by HSK Wiesbaden; the current stat…